Saturday 29 December 2012

Inhalant Approved for Agitation in Bipolar I, SchizophreniaInhalant Approved for Agitation in Bipolar I, Schizophrenia

FDA approves loxapine inhalation powder for acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults. FDA Approvals (Source: Medscape Today Headlines)

Source: http://www.medworm.com/index.php?rid=6876119&cid=u_0_26_f&fid=36062&url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F776682%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F776682%3Fsrc%3Drss

schools for phlebotomy phlebotomy training in michigan local phlebotomy classes

No comments:

Post a Comment